RareMed Solutions Maintains Top Ranking in Q4 2024 Patient Satisfaction Survey

RareMed Solutions is proud to announce that the company continues to lead the industry in patient experience, once again achieving the #1 Net Promotor Score (NPS) in the nation for Pharmacy Hubs in Q4 of 2024. RareMed remains the benchmark for high standards of care and continues to outperform competitors in the specialty pharmacy hubs category; a significant achievement highlighting our team’s commitment to care for our patients.  

RareMed’s unwavering commitment to delivering exceptional patient care is evident in key performance metrics, such as: 

  • 100% of RareMed patients are satisfied with prescription fill and refill time. 
  • 97% of patients are satisfied with the amount of time it takes to speak with a RareMed representative when they call with a question. 
  • RareMed continues to excel in treatment contact frequency and telephone hold time 

In addition to these metrics, patients continue to highlight RareMed Solutions customer service, timely and effective refill reminders, quick delivery of medications, and very professional and kind staff as key differentiators.  

The Q4 results from MMIT’s nationwide Patient Satisfaction Survey reaffirm RareMed’s dedication to serving patient populations that are often underserved. RareMed’s continued high performance is a testament to the company’s focus on providing the benchmark-setting care and enhancing patient satisfaction.  

RareMed Solutions actively participates in the MMIT surveys each quarter to stay attuned to patient feedback and leverage insights for continuous improvement. By prioritizing patient satisfaction and operation excellence, RareMed remains the industry leader in specialty pharmacy hubs, allowing us to change the lives of patients with rare and complex conditions.  

 

About RareMed    

RareMed Solutions is the nation’s only concierge patient services provider, focused on rare and complex conditions. RareMed partners with biopharma to transform the lives of patients afflicted with rare and devastating conditions by accelerating access to biomedical breakthroughs. RareMed offers case management, co-pay, coupon and financial assistance programs, reimbursement support, nursing support, healthcare professional education, patient adherence & education, and non-commercial pharmacy dispensing services to all fifty states, as well as custom-developed associated support technologies, from its headquarters in Pittsburgh, Pennsylvania and bases across the country.    

The company has a breadth of experience developing, transitioning, and maintaining therapy-specific solutions that ensure unparalleled manufacturer & patient satisfaction. RareMed’s undivided complex and rare disease focus, high caliber associates, fully dedicated teams, and sophisticated proprietary technology enable it to address the unique needs of complex and rare disease patients. RareMed has been recognized as a top workplace in the nation by USA Today and Newsweek, and consistently sets the benchmark for patient experience according to MMIT patient satisfaction surveys. Visit our website at www.RareMed.com.    

About Net Promoter Score    

The primary component of the MMIT Patient Satisfaction Survey is the Net Promoter Score (NPS). NPS is calculated by first asking patients how likely they would be to recommend a pharmacy to a friend or family member on a scale of 0-10. The percentage of patients that rate the pharmacy a 0-6, known as detractors, is subtracted from the percentage of patients that rate the pharmacy a 9 or 10, known as promoters, to create a score that ranges from –100 to 100. NPS is used by consumer facing companies to gauge consumer and brand loyalty.